Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma
מצבים רפואיים
Hepatocellular Carcinoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
CHU de Bordeaux, Bordeaux, France
Contact: Principal Investigator (Jean-Frédéric BLANC, Professor)AP-HP Hôpital Beaujon, Clichy, France
Contact: Principal Investigator (Mohamed BOUATTOUR, Doctor)Centre Georges Francois Leclerc, Dijon, France
Contact: Principal Investigator (Francois GHIRINGHELLI, Professor)Hôpital Saint Joseph, Marseille, France
Contact: Study coordinator (Xavier Adhoute) · xadhoute@hopital-saint-joseph.fr · +33 (0) 4 91 80 82 35CHU de Montpellier, Montpellier, France
Contact: Principal Investigator (Boris GUIU, Professor)CHU Hôtel-Dieu, Nantes, France
Contact: Principal Investigator (Yann TOUCHEFEU, Professor)AP-HP Hôpital Cochin, Paris, France
Contact: Principal Investigator (Anais VALLET-PICHARD, Doctor)CHU de Poitiers, Poitiers, France
Contact: Study coordinator (Marielle DUBREUIL) · marielle.dubreuil@chu-poitiers.fr · +33 5 16 60 42 34Contact: Principal Investigator (Amina LARBI, Doctor)Centre Eugene Marquis, Rennes, France
Contact: Principal Investigator (Julien EDELINE, Professor)CHRU de Strasbourg, Strasbourg, France
Contact: Study coordinator (Hakim TAYEBI) · Delegation_recherche@chru-strasbourg.fr · +33 3 88 11 51 58Contact: Principal Investigator (Antonio SAVIANO, Doctor)CHU de Rangueil, Toulouse, France
Contact: Principal Investigator (Jean-Marie PERON, Professor)
מובילי המחקר
Julien EDELINE, Professor
Principal Investigator
Centre Eugène Marquis
Laure Monard
Study Director
UNICANCER